Filing Details
- Accession Number:
- 0001797199-20-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-10 20:07:19
- Reporting Period:
- 2020-11-06
- Accepted Time:
- 2020-11-10 20:07:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1656472 | Cronos Group Inc. | CRON | Medicinal Chemicals & Botanical Products (2833) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1797199 | Ryan Michael Gorenstein | 111 Peter Street, Suite 300 Toronto A6 M5V 2G9 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Disposition | 2020-11-06 | 1,181,499 | $7.16 | 725,298 | No | 4 | S | Direct | |
Common Shares | Disposition | 2020-11-06 | 107,851 | $7.92 | 617,447 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.70 to $7.69, inclusive. The reporting person undertakes to provide to Cronos Group Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
- The total number of shares beneficially owned was misreported on the reporting person's Form 3 filed on December 31, 2019, which overreported the amount of beneficially owned shares by 100 shares. The number stated in this filing reflects the correction of the misreported amount.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.695 to $8.095, inclusive.